MPT stock: Eight analysts target USD 5.13 for Medical Properties Trust stock
Published on 10/22/2026 at 22:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSConsensus target and earnings date
- Eight analysts set a USD 5.13 consensus target on October 21, 2026.
- Second-quarter revenue reached USD 259.28 million, up 2.40 percent against consensus.
- Medical Properties Trust stock costs EUR 2.43 at Lang & Schwarz on October 22, 2026 at 10:45 p.m. CEST.
- Third-quarter results are scheduled for October 29, 2026.
Eight analysts put the consensus target for Medical Properties Trust at USD 5.13 on October 21, 2026, according to Investing.com. That target stood 89.11 percent above the USD 2.71 NYSE quote on October 22, 2026 at 4:00 p.m. ET. The stock was trading at EUR 2.43 at Lang & Schwarz on October 22, 2026 at 10:45 p.m. CEST.
Revenue reached USD 259.28 million
Medical Properties Trust reported USD 259.28 million in second-quarter 2026 revenue, 2.40 percent above the USD 253.28 million consensus estimate. Adjusted earnings per share were USD 0.15, while GAAP earnings per share were minus USD 0.01, according to Investing.com.
What does the next report test?
The next report will test whether revenue can hold near the second-quarter level while the trust manages tenant transitions. TradingView reported on October 22, 2026 that MPT will discuss third-quarter 2026 results on October 29, 2026 at 11:00 a.m. ET. The release is scheduled before the market opens that day.
Stock remains near its yearly low
The USD 2.71 NYSE quote was 4.00 percent above the 52-week low of USD 2.61 and 58.11 percent below the USD 6.47 high on October 22, 2026. Trading volume reached 16,849,000 shares, while market capitalization stood at USD 1.6 billion. The primary listing is the NYSE, and the company operates in healthcare real estate.
Hospital property remains the base
Medical Properties Trust is a self-advised real estate investment trust focused on net-leased hospital facilities. Its investor-relations page describes 373 facilities and approximately 38,000 licensed beds across nine countries as of June 30, 2026, a portfolio scale that keeps tenant performance central to the investment case. The company was formed in 2003, according to Medical Properties Trust.
Price and analyst distance
The USD 5.13 consensus target is 89.11 percent above the USD 2.71 NYSE quote. In contrast, the euro quotation provides a separate view for German investors, with no combined currency performance claim.
Investor dates and price
The next scheduled corporate date is October 29, 2026, when third-quarter results and the related conference call are due. The further course of trading is shown by the continuously updated real-time quote of Medical Properties Trust stock.
Medical Properties Trust stock facts
- Company: Medical Properties Trust, Inc.
- ISIN: US58463J3041
- Ticker: MPT
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 22, 2026, 10:45 p.m. CEST): EUR 2.43
- Market capitalization: USD 1.6 billion (as of October 22, 2026)
- 52-week range: USD 2.61-6.47 (as of October 22, 2026)
- Sector / Industry: Real Estate / Healthcare Facilities
- Next earnings date: October 29, 2026
Market context: Market report S&P 500.
